These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18605225)

  • 1. Challenges in natural health product research: The importance of standardization.
    Shan JJ; Rodgers K; Lai CT; Sutherland SK
    Proc West Pharmacol Soc; 2007; 50():24-30. PubMed ID: 18605225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmarket surveillance of natural health products in Canada: clinical and federal regulatory perspectives.
    Murty M
    Can J Physiol Pharmacol; 2007 Sep; 85(9):952-5. PubMed ID: 18066142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Issues related to botanicals.
    Khan IA
    Life Sci; 2006 Mar; 78(18):2033-8. PubMed ID: 16487545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Product development of probiotics as biological drugs.
    Sutton A
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S128-32; discussion S144-51. PubMed ID: 18181718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of gene therapy products and the impact of manufacturing changes on product comparability.
    Simek SL
    Dev Biol (Basel); 2005; 122():139-44. PubMed ID: 16375258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of natural products as a source of new antibiotics.
    Luzhetskyy A; Pelzer S; Bechthold A
    Curr Opin Investig Drugs; 2007 Aug; 8(8):608-13. PubMed ID: 17668363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The professionalization of Western herbalists: response to new product regulations in Canada.
    Moss K; Boon H; Ballantyne P; Kachan N
    Complement Ther Med; 2007 Dec; 15(4):264-70. PubMed ID: 18054728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current regulatory toxicology perspectives on the development of herbal medicines to prescription drug products in the United States.
    Wu KM; Ghantous H; Birnkrant DB
    Food Chem Toxicol; 2008 Aug; 46(8):2606-10. PubMed ID: 18614266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red Lapacho (Tabebuia impetiginosa)--a global ethnopharmacological commodity?
    Gómez Castellanos JR; Prieto JM; Heinrich M
    J Ethnopharmacol; 2009 Jan; 121(1):1-13. PubMed ID: 18992801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do natural compounds need specific drug development?
    Simon P; Verry M
    Prog Clin Biol Res; 1988; 280():407-21. PubMed ID: 3051029
    [No Abstract]   [Full Text] [Related]  

  • 11. Environmental assessment requirements for live biological drugs.
    Sutton A
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S112-4; discussion S144-51. PubMed ID: 18181713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who Expert Committee on Biological Standardization.
    World Health Organization
    World Health Organ Tech Rep Ser; 2004; 926():1-109. PubMed ID: 15918537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cordyceps fungi: natural products, pharmacological functions and developmental products.
    Zhou X; Gong Z; Su Y; Lin J; Tang K
    J Pharm Pharmacol; 2009 Mar; 61(3):279-91. PubMed ID: 19222900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural products as a robust source of new drugs and drug leads: past successes and present day issues.
    Rishton GM
    Am J Cardiol; 2008 May; 101(10A):43D-49D. PubMed ID: 18474274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Problems raising from the control of biological products employed in medicine. Control of sera, vaccines, and biological products in France].
    Desbordes J
    Ann Ist Super Sanita; 1969; 5(3-4):218-81. PubMed ID: 16089166
    [No Abstract]   [Full Text] [Related]  

  • 17. Premarket Regulation of Tissue Engineered Medical Products in China.
    Wang C; Wang A; Feng X; Ke L; Huang Y; Han Q; Sun X; Yang Z
    Tissue Eng Part A; 2015 Dec; 21(23-24):2806-11. PubMed ID: 26529310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral drug disposition and natural health products: risk of therapeutic alteration and resistance.
    MacDonald L; Murty M; Foster BC
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):563-78. PubMed ID: 19442034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of natural health products in Canada.
    Smith A; Jogalekar S; Gibson A
    J Ethnopharmacol; 2014 Dec; 158 Pt B():507-10. PubMed ID: 24969823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. St. John's wort - an overview.
    Linde K
    Forsch Komplementmed; 2009 Jun; 16(3):146-55. PubMed ID: 19657198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.